The Institutional Biosafety Committee (IBC) reviews all research activities involving recombinant or synthetic nucleic acids, as required by the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (revised 2024) and by University policy. Study teams indicate whether their project utilizes such technologies in the Master Project under Question 5.0 of the Project Specific Information section.
